Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,884 | 46,506 | 11,065 | 47,782 | 18,755 |
| Marketable Securities | 126,598 | 121,782 | 216,275 | 207,261 | 16,008 |
| Receivables | 4,682 | 5,778 | 13,087 | 6,877 | 5,172 |
| Inventories | 8,914 | 12,229 | 8,581 | 5,205 | 4,316 |
| TOTAL | $171,684 | $190,194 | $252,266 | $270,433 | $45,253 |
| Non-Current Assets | |||||
| PPE Net | 19,707 | 23,513 | 23,725 | 7,681 | 4,546 |
| Investments And Advances | 35,781 | 42,938 | 0 | 0 | 0 |
| Other Non-Current Assets | 12,298 | 11,629 | 10,662 | 6,006 | 1,981 |
| TOTAL | $67,786 | $78,080 | $34,387 | $13,687 | $6,527 |
| Total Assets | $239,470 | $268,274 | $286,653 | $284,120 | $51,780 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,358 | 743 | 292 | 1,820 | 890 |
| Accrued Expenses | 8,302 | 11,269 | 8,265 | 6,524 | 5,309 |
| TOTAL | $15,775 | $17,855 | $15,427 | $15,618 | $11,614 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 4,917 |
| Deferred Revenues | 5,251 | 5,069 | 6,713 | 6,747 | 4,843 |
| Other Non-Current Liabilities | 17,444 | 18,252 | 17,258 | 5,605 | 2,023 |
| TOTAL | $17,444 | $18,252 | $17,258 | $5,605 | $6,940 |
| Total Liabilities | $33,219 | $36,107 | $32,685 | $21,223 | $18,555 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,028 | 104,129 | 102,905 | 101,540 | N/A |
| Common Shares | 1,057 | 1,040 | 1,024 | 1,012 | 774 |
| Retained earnings | -216,853 | -175,798 | -137,875 | -114,305 | -95,222 |
| TOTAL | $206,251 | $232,167 | $253,968 | $262,897 | $33,225 |
| Total Liabilities And Equity | $239,470 | $268,274 | $286,653 | $284,120 | $51,780 |